Resultaträkning Veeva Systems Inc.
Aktier
VEEV
US9224751084
Avancerad medicinsk utrustning & teknologi
Marknaden stängd -
Andra börsplatser
|
5-dagars förändring | Förändring 1 jan. | ||
250,45 USD | +8,11 % | +9,92 % | +30,09 % |
06.12. | Veeva Systems Insider sålde aktier värda $ 390,128, enligt en ny SEC-arkivering | MT |
06.12. | Sektoruppdatering: Hälsovårdsaktierna högre före marknaden på fredag | MT |
Skatteperiod: Januari | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,1 md | 1,47 md | 1,85 md | 2,16 md | 2,36 md | |||||
Total Revenues | 1,1 md | 1,47 md | 1,85 md | 2,16 md | 2,36 md | |||||
Cost of Goods Sold, Total | 303 mn | 409 mn | 504 mn | 609 mn | 677 mn | |||||
Gross Profit | 801 mn | 1,06 md | 1,35 md | 1,55 md | 1,69 md | |||||
Selling General & Admin Expenses, Total | 303 mn | 384 mn | 460 mn | 566 mn | 628 mn | |||||
R&D Expenses | 210 mn | 294 mn | 382 mn | 520 mn | 629 mn | |||||
Other Operating Expenses, Total | 513 mn | 678 mn | 842 mn | 1,09 md | 1,26 md | |||||
Operating Income | 288 mn | 378 mn | 505 mn | 459 mn | 429 mn | |||||
Interest And Investment Income | 25,18 mn | 15,86 mn | 14,73 mn | 45,86 mn | 134 mn | |||||
Net Interest Expenses | 25,18 mn | 15,86 mn | 14,73 mn | 45,86 mn | 134 mn | |||||
Currency Exchange Gains (Loss) | −708 tn | 2,28 mn | −714 tn | 591 tn | 124 tn | |||||
Other Non Operating Income (Expenses) | - | 1,15 mn | - | 572 tn | - | |||||
EBT, Excl. Unusual Items | 312 mn | 397 mn | 520 mn | 506 mn | 563 mn | |||||
Merger & Related Restructuring Charges | −1,3 mn | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 3 mn | −3,08 mn | −7,2 mn | 2,98 mn | 24,82 mn | |||||
EBT, Incl. Unusual Items | 314 mn | 394 mn | 512 mn | 509 mn | 588 mn | |||||
Income Tax Expense | 12,58 mn | 14 mn | 84,92 mn | 21,39 mn | 62,32 mn | |||||
Earnings From Continuing Operations | 301 mn | 380 mn | 427 mn | 488 mn | 526 mn | |||||
Net Income to Company | 301 mn | 380 mn | 427 mn | 488 mn | 526 mn | |||||
Net Income - (IS) | 301 mn | 380 mn | 427 mn | 488 mn | 526 mn | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | 301 mn | 380 mn | 427 mn | 488 mn | 526 mn | |||||
Net Income to Common Excl. Extra Items | 301 mn | 380 mn | 427 mn | 488 mn | 526 mn | |||||
Per aktie poster | ||||||||||
Net EPS - Basic | 2,04 | 2,52 | 2,79 | 3,14 | 3,27 | |||||
Basic EPS - Continuing Operations | 2,04 | 2,52 | 2,79 | 3,14 | 3,27 | |||||
Basic Weighted Average Shares Outstanding | 148 mn | 151 mn | 153 mn | 155 mn | 161 mn | |||||
Net EPS - Diluted | 1,9 | 2,36 | 2,63 | 3 | 3,22 | |||||
Diluted EPS - Continuing Operations | 1,9 | 2,36 | 2,63 | 3 | 3,22 | |||||
Diluted Weighted Average Shares Outstanding | 158 mn | 161 mn | 162 mn | 162 mn | 163 mn | |||||
Normalized Basic EPS | 1,32 | 1,65 | 2,12 | 2,04 | 2,19 | |||||
Normalized Diluted EPS | 1,23 | 1,54 | 2 | 1,95 | 2,15 | |||||
Kompletterande punkter | ||||||||||
EBITDA | 307 mn | 407 mn | 533 mn | 488 mn | 462 mn | |||||
EBITA | 298 mn | 398 mn | 524 mn | 478 mn | 448 mn | |||||
EBIT | 288 mn | 378 mn | 505 mn | 459 mn | 429 mn | |||||
EBITDAR | 316 mn | 420 mn | 547 mn | 504 mn | 478 mn | |||||
Total Revenues (As Reported) | 1,1 md | 1,47 md | 1,85 md | 2,16 md | 2,36 md | |||||
Effective Tax Rate - (Ratio) | 4,01 | 3,55 | 16,58 | 4,2 | 10,6 | |||||
Current Domestic Taxes | 15,84 mn | 11,87 mn | 66,01 mn | 140 mn | 156 mn | |||||
Current Foreign Taxes | 3,4 mn | 2,82 mn | 7,84 mn | 8,51 mn | 12,16 mn | |||||
Total Current Taxes | 19,24 mn | 14,7 mn | 73,84 mn | 149 mn | 168 mn | |||||
Deferred Domestic Taxes | −1,58 mn | −135 tn | 2,82 mn | −120 mn | −103 mn | |||||
Deferred Foreign Taxes | −5,08 mn | −566 tn | 8,26 mn | −7,82 mn | −1,98 mn | |||||
Total Deferred Taxes | −6,66 mn | −701 tn | 11,08 mn | −128 mn | −105 mn | |||||
Normalized Net Income | 195 mn | 248 mn | 325 mn | 316 mn | 352 mn | |||||
Kompletterande driftskostnadsposter | ||||||||||
Advertising Expense | - | - | - | - | - | |||||
Selling and Marketing Expenses | 190 mn | 235 mn | 288 mn | 349 mn | 381 mn | |||||
General and Administrative Expenses | 113 mn | 149 mn | 172 mn | 218 mn | 247 mn | |||||
Research And Development Expense From Footnotes | 210 mn | 294 mn | 382 mn | 520 mn | 629 mn | |||||
Net Rental Expense, Total | 8,3 mn | 13 mn | 14 mn | 16 mn | 16 mn | |||||
Stock-Based Comp., COGS (Total) | 20,16 mn | 32,54 mn | 41,09 mn | 56,6 mn | 59,72 mn | |||||
Stock-Based Comp., R&D Exp. (Total) | 37 mn | 63,54 mn | 83,84 mn | 142 mn | 173 mn | |||||
Stock-Based Comp., S&M Exp. (Total) | 27,54 mn | 40,57 mn | 56,83 mn | 87,51 mn | 90,86 mn | |||||
Stock-Based Comp., G&A Exp. (Total) | 31,21 mn | 48,35 mn | 52,88 mn | 66,23 mn | 70,27 mn | |||||
Total Stock-Based Compensation | 116 mn | 185 mn | 235 mn | 352 mn | 394 mn |